Helicobacter pylori in First Nations and recent immigrant populations in Canada.

The diminishing prevalence of Helicobacter pylori infection among most segments of the Canadian population has led to changes in the etiologies and patterns of associated upper gastrointestinal diseases, including fewer peptic ulcers and their complications. Canadian Aboriginals and recent immigrants are among populations in which the prevalence of H pylori infection remains high and, therefore, the health risks imposed by H pylori remain a significant concern. Population-based strategies for H pylori eradication in groups with a low prevalence of infection are unlikely to be cost effective, but such measures are attractive in groups in which the prevalence rates of infection remain substantial. In addition to a lower prevalence of peptic ulcers and dyspepsia, the public health value of eradication may be particularly important if this leads to a reduction in the prevalence of gastric cancer in high prevalence groups. Therefore The Canadian Helicobacter Study Group held a conference that brought together experts in the field to address these issues, the results of which are reviewed in the present article. Canadians with the highest prevalence of H pylori infection are an appropriate focus for considering the health advantages of eradicating persistent infection. In Canadian communities with a high prevalence of both H pylori and gastric cancer, there remains an opportunity to test the hypothesis that H pylori infection is a treatable risk factor for malignancy.

[1]  G. Capellá,et al.  Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain , 2011, The American Journal of Gastroenterology.

[2]  C. Hassan,et al.  Helicobacter pylori in immigrants: a “foreign” bacterium? , 2011, Internal and emergency medicine.

[3]  A. Egloff,et al.  Response to Combined Molecular Targeting: Defining the Role of P-STAT3 , 2011, Clinical Cancer Research.

[4]  D. Graham,et al.  Strategy for Eliminating Gastric Cancer in Japan , 2010, Helicobacter.

[5]  H. Funahashi,et al.  Strategies for gastric cancer in the modern era. , 2010, World journal of gastrointestinal oncology.

[6]  C. O'Morain,et al.  Treatment of Helicobacter pylori Infection 2010 , 2010, Helicobacter.

[7]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[8]  Hong Lu,et al.  High Efficacy of 14‐Day Triple Therapy‐Based, Bismuth‐Containing Quadruple Therapy for Initial Helicobacter pylori Eradication , 2010, Helicobacter.

[9]  C. Streutker,et al.  Retrospective clinico-pathologic review of gastric cancer in an inner city Canadian hospital. , 2010 .

[10]  K. McColl Clinical practice. Helicobacter pylori infection. , 2010, The New England journal of medicine.

[11]  Hsiu‐Po Wang,et al.  Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design , 2010, Gut.

[12]  P. Hotez Neglected Infections of Poverty among the Indigenous Peoples of the Arctic , 2010, PLoS neglected tropical diseases.

[13]  I. Choi,et al.  Cost‐Effectiveness of Eradication of Helicobacter pylori in Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer , 2009, Helicobacter.

[14]  J. Gisbert Review: Second-line rescue therapy of Helicobacter pylori infection , 2009, Therapeutic advances in gastroenterology.

[15]  Sm,et al.  and Gastric Cancer , 2009 .

[16]  D. Graham,et al.  Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing „Concomitant Therapy“ Versus Triple Therapy for Helicobacter pylori Eradication , 2009 .

[17]  A. Corriveau,et al.  Helicobacter pylori infection in Canada's arctic: searching for the solutions. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[18]  C. O'Morain,et al.  Treatment of Helicobacter pylori Infection , 2008, Helicobacter.

[19]  David K. Espey,et al.  Gastric cancer among American Indians and Alaska Natives in the United States, 1999–2004 , 2008, Cancer.

[20]  LaTisha L. Marshall,et al.  Lung cancer incidence among American Indians and Alaska Natives in the United States, 1999–2004 , 2008, Cancer.

[21]  M. Asaka,et al.  Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial , 2008, The Lancet.

[22]  N. Luo,et al.  Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. , 2008, World journal of gastroenterology.

[23]  R. Holman,et al.  Epidemiology of hospitalizations associated with ulcers, gastric cancers, and Helicobacter pylori infection among American Indian and Alaska Native persons. , 2008, The American journal of tropical medicine and hygiene.

[24]  D. Armstrong,et al.  Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[25]  K. Jacobson,et al.  Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[26]  R. Hunt,et al.  Asia–Pacific consensus guidelines on gastric cancer prevention , 2008, Journal of gastroenterology and hepatology.

[27]  R. Tao,et al.  Effects of H pylori infection on gap-junctional intercellular communication and proliferation of gastric epithelial cells in vitro. , 2007, World journal of gastroenterology.

[28]  F. Bazzoli,et al.  Meta-analysis: Duration of First-Line Proton-Pump InhibitorBased Triple Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.

[29]  A. Boussioutas,et al.  Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression , 2007, The Journal of pathology.

[30]  N. Kreiger,et al.  Helicobacter pylori infection in Ontario: prevalence and risk factors. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[31]  M. Beller,et al.  Helicobacter pylori infection among non-Native educators in Alaska , 2007, International journal of circumpolar health.

[32]  T. Wang,et al.  Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.

[33]  C. O'Morain,et al.  Treatment of Helicobacter pylori Infection , 2006, Helicobacter.

[34]  W. Chey,et al.  Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis , 2006, The American Journal of Gastroenterology.

[35]  M. Leinonen,et al.  Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  J. Parsonnet,et al.  Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. , 2005, American journal of epidemiology.

[37]  Y. Yamaji,et al.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.

[38]  R. Hunt Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? , 2004, The American journal of medicine.

[39]  K. Krogfelt,et al.  Helicobacter pylori infection in Greenlandic patients with dyspepsia , 2004, International journal of circumpolar health.

[40]  R. Hunt,et al.  Helicobacter pylori and the prevention of gastric cancer. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[41]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[42]  M. Stolte,et al.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.

[43]  A. Barkun,et al.  The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study , 2003, Alimentary pharmacology & therapeutics.

[44]  R. Hunt,et al.  Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A , 2003, American Journal of Gastroenterology.

[45]  C. Bernstein,et al.  Age at Acquisition of Helicobacter pylori in a Pediatric Canadian First Nations Population , 2002, Helicobacter.

[46]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[47]  B. Swaminathan,et al.  High Prevalence of Helicobacter pylori in the Alaska Native Population and Association with Low Serum Ferritin Levels in Young Adults , 2000, Clinical Diagnostic Laboratory Immunology.

[48]  J. Everhart Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.

[49]  J. Everhart,et al.  Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. , 2000, The Journal of infectious diseases.

[50]  B. Molnár,et al.  Increased Cell Proliferation in Chronic Helicobacter pylori Positive Gastritis and Gastric Carcinoma – Correlation between Immuno-Histochemistry and Tv Image Cytometry , 2000, Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology.

[51]  E. Kliewer,et al.  Seroprevalence of Helicobacter pylori, Incidence of Gastric Cancer, and Peptic Ulcer-Associated Hospitalizations in a Canadian Indian Population , 1999, Digestive Diseases and Sciences.

[52]  N. Talley,et al.  Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. , 1997, The American journal of gastroenterology.

[53]  D. Ahlquist,et al.  Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. , 1997, JAMA.

[54]  J. H. Baron,et al.  Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection , 1997, BMJ.

[55]  Douglas K Owens,et al.  Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials , 1996, The Lancet.

[56]  C. Lamers,et al.  Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease , 1996, European journal of gastroenterology & hepatology.

[57]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[58]  B. Collins,et al.  Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up , 1994, The Lancet.

[59]  P. Sherman,et al.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[60]  E Hentschel,et al.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. , 1993, The New England journal of medicine.

[61]  T. Dragani,et al.  Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .

[62]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[63]  D. Graham,et al.  Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. , 1991, Digestive diseases and sciences.

[64]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[65]  D. Graham,et al.  Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. , 1991, Gastroenterology.

[66]  J. Samet,et al.  Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. , 1989, Cancer research.

[67]  S. Zenios,et al.  An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[68]  M. Ezzati,et al.  Exploring the cost‐effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results , 2009, International journal of cancer.

[69]  C. Bernstein,et al.  Helicobacter pylori in the Canadian arctic: seroprevalence and detection in community water samples , 1999, American Journal of Gastroenterology.

[70]  Y. Nikitin,et al.  Helicobacter pylori in a Chukotka Native male population. , 1998, International journal of circumpolar health.

[71]  E. El-Omar,et al.  Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. , 1998, British medical bulletin.

[72]  R. Hunt,et al.  Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[73]  E. Kuipers,et al.  The prevalence of Helicobacter pylori in peptic ulcer disease. , 1995, Alimentary pharmacology & therapeutics.

[74]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.